SCHEMBL23818990

SCHEMBL23818990

CCCOC(=O)[C@H](C)N[PH](=O)OC[C@@](C#N)(OC)[C@@H](OC(=O)C(C)C)[C@@H](OC(=O)C(C)C)c1ccc2c(N)ncnn12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26333558 0.96 — —
SCHEMBL23819242 0.93 — —
SCHEMBL26333107 0.92 — —
SCHEMBL23818667 0.92 — —
SCHEMBL26336063 0.89 RIPK1 (0.32) —
SCHEMBL23819025 0.88 — —
SCHEMBL26345179 0.88 RIPK1 (0.31) —
SCHEMBL26334372 0.88 RIPK1 (0.31) —
SCHEMBL23819263 0.88 — —
SCHEMBL23819087 0.87 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767337-B2 Antiviral compounds GILEAD SCIENCES, INC. (US) 2023-09-26 — — US disclosed
US-20210284670-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2021-09-16 — — US disclosed
Send feedback